{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_3", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "medicines during pregnancy and breastfeeding is presented in th e labeling of prescription \ndrugs and biological products.  FDA also  issued a draft guidance for industry to assist drug \nmanufacturers in complying with the new labeling content and format requirements.  FDA has \nposted quite a bit on this topic, but we hope that this quick two -page summary will help you \nobtain an overview of the requirements, along with where to find detailed information. \n \nHighlights of the PLLR include: \n \n1"}